https://harbinger-health.com/reflexing-in-the-right-direction-two-tier-testing-for-early-cancer-screening/ 2026-03-04T17:12:17+00:00 https://harbinger-health.com/understanding-ppv-and-npv-in-healthcare-testing-crucial-tools-for-diagnostic-accuracy/ 2026-03-04T17:24:30+00:00 https://harbinger-health.com/high-risk-populations-and-the-importance-of-cancer-screening/ 2026-03-05T22:30:58+00:00 https://harbinger-health.com/the-power-of-ai-in-early-cancer-detection/ 2026-03-05T22:32:08+00:00 https://harbinger-health.com/flagship-pioneering-launches-harbinger-health-to-detect-early-cancer-with-a-simple-bio-ai-based-blood-test/ 2026-03-05T22:32:51+00:00 https://harbinger-health.com/harbinger-health-and-sarah-cannon-research-institute-launch-clinical-study-to-validate-and-advance-development-of-harbingers-novel-early-cancer-detection-platform/ 2026-03-05T22:33:45+00:00 https://harbinger-health.com/harbinger-health-appoints-vincent-lozada-as-chief-financial-officer/ 2026-03-05T22:34:32+00:00 https://harbinger-health.com/harbinger-health-announces-results-demonstrating-high-sensitivity-of-early-stage-multi-cancer-detection-platform-at-asco-annual-meeting-2023/ 2026-03-05T22:35:43+00:00 https://harbinger-health.com/harbinger-health-appoints-may-orfali-m-d-as-chief-medical-officer/ 2026-03-05T22:36:33+00:00 https://harbinger-health.com/harbinger-health-announces-data-demonstrating-its-ability-to-detect-early-stage-multi-cancer-at-the-aacc-annual-scientific-meeting-2023/ 2026-03-05T22:37:25+00:00 https://harbinger-health.com/harbinger-health-expands-industry-leading-executive-team/ 2026-03-05T22:38:42+00:00 https://harbinger-health.com/harbinger-health-raises-140-million-in-series-b-funding-to-accelerate-advancement-of-its-screening-platform-for-early-stage-cancers/ 2026-03-05T22:39:22+00:00 https://harbinger-health.com/harbinger-health-begins-new-clinical-study-in-individuals-at-high-risk-for-cancer/ 2026-03-05T22:40:04+00:00 https://harbinger-health.com/harbinger-health-announces-new-partnership-with-leading-cancer-center-to-accelerate-clinical-evidence-generation/ 2026-03-05T22:41:01+00:00 https://harbinger-health.com/harbinger-health-presents-data-demonstrating-novel-capabilities-of-its-computational-platform-to-enhance-performance-and-clinical-informativeness-in-blood-based-early-cancer-detection/ 2026-03-05T22:41:38+00:00 https://harbinger-health.com/harbinger-health-announces-data-showcasing-product-innovations-of-its-blood-based-platform-for-early-cancer-detection/ 2026-03-05T22:42:31+00:00 https://harbinger-health.com/harbinger-health-strengthens-leadership-team-and-board-of-directors/ 2026-03-05T22:43:08+00:00 https://harbinger-health.com/harbinger-health-unveils-promising-new-data-on-early-cancer-detection-platform-at-aacr-2025/ 2026-03-05T22:43:55+00:00 https://harbinger-health.com/harbinger-health-mced-performance-high-risk-populations-asco-2025/ 2026-03-05T22:44:58+00:00 https://harbinger-health.com/a-conversation-about-access/ 2026-03-05T22:46:44+00:00 https://harbinger-health.com/wp-content/uploads/2026/03/platform-technology-hero.webp https://harbinger-health.com/ajit-singh-appointed-ceo-of-harbinger-health-and-ceo-partner-of-flagship-pioneering/ 2026-03-07T21:57:26+00:00 https://harbinger-health.com/wp-content/uploads/2025/08/featured-post-cell-closeup.webp https://harbinger-health.com/performance-evaluation-of-a-reflex-blood-based-methylated-ctdna-multi-cancer-early-detection-test-in-individuals-with-obesity/ 2026-03-27T19:24:29+00:00 https://harbinger-health.com/extracting-tumor-signal-from-cell-free-dna-using-deep-neural-networks-improves-early-cancer-detection/ 2026-03-27T19:24:59+00:00 https://harbinger-health.com/analytical-and-clinical-validation-of-a-methylation-based-cfdna-assay-for-early-detection-of-high-mortality-cancers-using-a-cost-efficient-reflex-approach/ 2026-04-07T16:37:32+00:00 https://harbinger-health.com/stastical-methodology-for-mced-metrics/ 2026-04-08T16:55:37+00:00 https://harbinger-health.com/harbinger-healths-technical-optimization-and-assessment-of-xgen-hybridization-and-wash-v3-kit-support-application-for-high-throughput-targeted-methyl-sequencing/ 2026-04-08T16:58:35+00:00 https://harbinger-health.com/validation-of-a-reflex-cfdna-methylation-based-multi-cancer-early-detection-mced-blood-test-in-individuals-with-obesity/ 2026-04-08T17:00:46+00:00 https://harbinger-health.com/blood-based-mced-testing-during-routine-colonoscopies-to-enhance-early-detection-of-high-mortality-gastrointestinal-cancers/ 2026-04-08T17:03:15+00:00 https://harbinger-health.com/validation-of-a-reflex-cfdna-methylation-based-multi-cancer-early-detection-mced-blood-test-for-tumors-lacking-routine-screening-in-asymptomatic-adults/ 2026-04-08T17:05:20+00:00 https://harbinger-health.com/gem-a-deep-generative-framework-for-synthetic-generation-of-plasma-cfdna-methylation-profiles/ 2026-04-08T17:07:11+00:00 https://harbinger-health.com/using-cell-type-deconvolution-to-add-immune-metastatic-and-health-context-tomethylation-based-early-cancer-detection/ 2026-04-08T17:09:32+00:00 https://harbinger-health.com/d-fract-enhances-detection-of-tumor-derived-cfdna-fragments-and-cancer-tissue-signal-in-liquid-biopsy/ 2026-04-08T17:12:27+00:00 https://harbinger-health.com/novel-performance-quantification-of-mced-testing-to-aid-clinical-decisions-analysis-of-a-sequential-reflex-blood-based-methylated-ctdna-test/ 2026-04-08T17:14:15+00:00 https://harbinger-health.com/sharpening-the-signal-enhancing-liquid-biopsy-specificity-through-intra-individual-methylation-analysis/ 2026-04-08T17:16:06+00:00 https://harbinger-health.com/a-methylation-state-specific-targeted-background-depletion-technique-for-enrichment-of-ctdna-fraction/ 2026-04-08T17:18:17+00:00 https://harbinger-health.com/a-real-time-pcr-method-for-the-detection-of-cancer-specific-methylation-patterns-in-cfdna/ 2026-04-08T17:20:25+00:00 https://harbinger-health.com/transfer-learning-for-accurate-tissue-of-origin-classification-from-cfdna-methylation/ 2026-04-08T17:22:27+00:00 https://harbinger-health.com/liquid-biopsy-based-detection-of-triple-negative-breast-cancer-at-0-5-tumor-content-using-dna-methylation-biomarkers/ 2026-04-08T17:24:08+00:00 https://harbinger-health.com/a-large-scale-data-simulation-platform-isolates-tumor-signal-from-cell-free-dna-and-improves-tissue-of-origin-prediction-accuracy/ 2026-04-08T17:26:46+00:00 https://harbinger-health.com/dna-library-amplification-to-produce-archived-reference-samples-for-rd-and-clinical-assay-development-optimization-and-validation/ 2026-04-08T17:28:56+00:00 https://harbinger-health.com/non-invasive-longitudinal-analysis-of-cancer-signal-to-monitor-disease-progression-and-response-to-treatment/ 2026-04-08T17:30:48+00:00 https://harbinger-health.com/novel-blood-based-assay-for-early-cancer-detection-demonstrates-high-precision-and-reproducibility-on-low-tumor-content/ 2026-04-08T17:32:26+00:00 https://harbinger-health.com/harbinger-health-establishes-resolve-as-a-new-category-for-cancer-detection/ 2026-04-14T10:21:19+00:00 https://harbinger-health.com/harbinger-health-presents-multiple-studies-at-aacr-reinforcing-platform-foundation-for-resolve-a-new-category-for-cancer-detection/ 2026-04-17T10:15:28+00:00